Form 8-K - Current report:
SEC Accession No. 0001213900-25-033956
Filing Date
2025-04-22
Accepted
2025-04-22 08:42:26
Documents
14
Period of Report
2025-04-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239079-8k_enzo.htm   iXBRL 8-K 21915
2 PRESS RELEASE OF ENZO BIOCHEM, INC. DATED APRIL 22, 2025 ea023907901ex99-1_enzo.htm EX-99.1 9071
  Complete submission text file 0001213900-25-033956.txt   203485

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20250422.xsd EX-101.SCH 2999
4 XBRL LABEL FILE enz-20250422_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE enz-20250422_pre.xml EX-101.PRE 22349
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0239079-8k_enzo_htm.xml XML 3456
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 25855637
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)